Clinical trial
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery…
NCT00429923 · Sirion Therapeutics, Inc., Industry · Completed
Key facts
| NCT number | NCT00429923 |
|---|---|
| Title | Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a) |
| Official title | A Phase 3 Multicenter, Randomized, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Difluprednate in the Treatment of Inflammation Following Ocular Surgery |
| Lead sponsor | Sirion Therapeutics, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Inflammation |
| Intervention type | Drug |
| Interventions | Difluprednate, Placebo |
| Enrollment | 219 |
| First posted | Feb 1, 2007 |
| Last update posted | Jul 2, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: